Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Insurance (& InsurTech) • Payments • Consumer |
Stages | Pre-Seed, Seed, Early Stage, Series A, Series B, Secondary Market, Venture |
Investing | Germany • France |
Investment Range | $50,000 - $2,000,000 |
Investment Sweet Spot | $150,000 |
Kima Ventures is a prominent venture capital firm based in Paris, France, known for being one of the world's most active business angels. Since its establishment in 2010, the firm has been specializing in a diverse set of industries, including but not limited to Software, BioTech, Business Solutions, FinTech, Hardware, Retail, IoT, CleanTech, A.I., HealthTech, Web Security, Insurance, Payments, and Consumer goods. They are focused on investing in early-stage startups that exhibit a strong tech DNA and are founded by French entrepreneurs, regardless of their global location. They are sector-agnostic, with a preference for companies operating across hardware, robotics, e-commerce, SaaS, marketplace, big data, finance, media, mobile, security, and other high-tech sectors. Kima Ventures offers one-off investment tickets of EUR 150,000 and considers investments ranging from a minimum of EUR 50,000 to a maximum of EUR 2,000,000. They actively seek to invest in Pre-Seed, Seed, Early Stage, Series A, Series B, and the Secondary Market ventures. On their website, they proclaim to backing two startups per week with both capital and operational support, reinforcing their commitment to fostering growth in promising ventures. Kima Ventures adopts a comprehensive approach to sourcing and nurturing potential, as reflected in their diverse and robust portfolio, which witnesses multiple investments in sectors like energy efficiency, auction technology, document organization and analytics, evidence-based medicine, and conversational A.I. platforms.
We invest in early-stage startups with strong tech DNA, founded by French founders wherever they're in the world. We're sector agnostic and investing one-off tickets of 150k€.